Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate
Authors:
- L.G. WangLWL.G. Wang
- X.M. LiuXLX.M. Liu
Open Access
- 16 May 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 27 (10) , 2124-2132
Abstract
Background: Prostate cancer usually progresses to androgen refractory after an initial anti-androgen treatment. The androgen receptor (AR) is a pivotal factor for the androgen-mediated growth and maintenance of the prostate. Abnormality of the AR, such as overexpression has been postulated to be related to the hormone independent growth of the cancer. Although we previously demonstrated that the AR expression could be modulated by isothiocyanates, which are natural constituents of cruciferous vegetables, the mechanism, however, remained to be clarified. We have since investigated the mechanism of phenethyl isothiocyanate (PEITC) in AR regulation. Methods: A human androgen dependent prostate cancer cell line LNCaP (AD) and its sub-line LNCaP (AI), i.e. androgen independent but overexpressing AR, were exposed to PEITC. The effects of PEITC on cell growth and AR expression/transcription were analyzed with MTT assay, real-time PCR and western blotting. The AR promoter activity was analyzed with the reporter activity after transfection with pAR-luc. The effects on Sp1, the major transcription factor of the AR, were tested with Sp1-luc activity, western blotting and electrophoretic mobility shift assay. Results: PEITC induced a significant growth inhibition, with equal IC 50 , in both AD and AI cells. The AR present in both cells was repressed as demonstrated with real-time PCR and western blot. PEITC mediates dual effects at transcriptional and post-translational levels to regulate the AR. At transcriptional level the AR level was reduced via inhibition of the transcription factor Sp1, and at post-translational level by accelerating protein degradation. Conclusion: PEITC represses AR transcription and expression, and mediates growth arrest in androgen dependent and independent prostate cancer cells. With the AR modulation and growth attenuation, PEITC and possibly other isothiocyanates, may prevent and inhibit hormone sensitive and refractory prostate cancer.Keywords
This publication has 40 references indexed in Scilit:
- Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- The androgen receptor: a potential target for therapy of prostate cancerSteroids, 2004
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003
- Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor LevelsBiochemical and Biophysical Research Communications, 2000
- Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivativeJournal of Cellular Physiology, 1999
- Functional analysis of the human androgen receptor promoterMolecular and Cellular Endocrinology, 1996
- Induction of translation by the 5'-untranslated region of human androgen receptor mRNA.Journal of Biological Chemistry, 1994
- The rat androgen receptor gene promoterMolecular and Cellular Endocrinology, 1990
- Recent studies of the androgen receptor: new insights into old questionsMolecular and Cellular Endocrinology, 1990
- An estimate of the mean daily intake of glucosinolates from cruciferous vegetables in the UKJournal of the Science of Food and Agriculture, 1984